Literature DB >> 11392377

The effects of oestrogens on linear bone growth.

A Juul1.   

Abstract

Regulation of linear bone growth in children and adolescents comprises a complex interaction of hormones and growth factors. Growth hormone (GH) is considered to be the key hormone regulator of linear growth in childhood. The pubertal increase in growth velocity associated with GH has traditionally been attributed to testicular androgen secretion in boys, and to oestrogens or adrenal androgen secretion in girls. Research data indicating that oestrogen may be the principal hormone stimulating the pubertal growth spurt in boys as well as girls is reviewed. Such an action is mediated by oestrogen receptors (ER-alpha and ER-beta) in the human growth plate, and polymorphisms in the ER gene may influence adult height in healthy subjects. Prepubertal oestradiol concentrations are significantly higher in girls than in boys, explaining sex-related differences in pubertal onset. Men with a disruptive mutation in the ER gene (oestrogen resistance) or in the CYP19 gene (aromatase deficiency) who have no pubertal growth spurt and continue to grow into adulthood due to lack of epiphyseal fusion supports this notion. Furthermore, phenotypic females with complete androgen insensitivity syndrome have a normal female growth spurt despite lack of androgen action. Oestrogens may also influence linear bone growth indirectly via modulation of the GH-insulin-like growth factor-I (IGF-I) axis. Thus, ER blockade diminishes endogenous GH secretion, androgen receptor (AR) blockade increases GH secretion in peripubertal boys, and non-aromatizable androgens [oxandrolone or dihydrotestosterone (DHT)] have no effect on GH secretion. Treatment with aromatase inhibitors reduces circulating IGF-I concentrations in healthy males, and reduces growth in boys with testotoxicosis. Taken together, these findings suggest that oestrogens may, in addition to their direct effects, stimulate GH secretion and thereby increase circulating IGF-I, which in turn may stimulate growth. Thus, oestrogens have important biphasic actions on longitudinal growth in boys as well as in girls. Very low levels of oestrogens may stimulate bone growth without affecting sexual maturation directly at the growth plate as well as through stimulation of the GH-IGF axis, which in turn may stimulate growth. Conversely, higher levels of oestrogens stimulate secondary sexual characteristics and epiphyseal fusion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392377     DOI: 10.1093/humupd/7.3.303

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  34 in total

Review 1.  Genomic and non-genomic actions of sex steroids in the growth plate.

Authors:  Marcel Karperien; Bram C J van der Eerden; Jan Maarten Wit
Journal:  Pediatr Nephrol       Date:  2005-02-03       Impact factor: 3.714

2.  Insulin does not rescue cortical and trabecular bone loss in type 2 diabetic Goto-Kakizaki rats.

Authors:  Ratchaneevan Aeimlapa; Narattaphol Charoenphandhu; Panan Suntornsaratoon; Kannikar Wongdee; Wacharaporn Tiyasatkulkovit; Kanchana Kengkoom; Nateetip Krishnamra
Journal:  J Physiol Sci       Date:  2017-07-08       Impact factor: 2.781

3.  Association between CYP19A1 genotype and pubertal sagittal jaw growth.

Authors:  Shushu He; James K Hartsfield; Yujiao Guo; Yang Cao; Si Wang; Song Chen
Journal:  Am J Orthod Dentofacial Orthop       Date:  2012-11       Impact factor: 2.650

4.  The estrogen receptor antagonist ICI 182,780 can act both as an agonist and an inverse agonist when estrogen receptor α AF-2 is modified.

Authors:  Sofia Movérare-Skrtic; Anna E Börjesson; Helen H Farman; Klara Sjögren; Sara H Windahl; Marie K Lagerquist; Annica Andersson; Alexandra Stubelius; Hans Carlsten; Jan-Åke Gustafsson; Claes Ohlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-06       Impact factor: 11.205

Review 5.  The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice.

Authors:  Lisa E Olson; Claes Ohlsson; Subburaman Mohan
Journal:  Calcif Tissue Int       Date:  2010-11-27       Impact factor: 4.333

6.  Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

Authors:  Kristen E Govoni; Jon E Wergedal; Robert B Chadwick; Apurva K Srivastava; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-23       Impact factor: 4.310

Review 7.  Androgens and bone.

Authors:  Bart L Clarke; Sundeep Khosla
Journal:  Steroids       Date:  2008-10-17       Impact factor: 2.668

8.  Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.

Authors:  Jessica Rb Musselman; Tracy L Bergemann; Julie A Ross; Charles Sklar; Kevin At Silverstein; Erica K Langer; Sharon A Savage; Rajaram Nagarajan; Mark Krailo; David Malkin; Logan G Spector
Journal:  Int J Mol Epidemiol Genet       Date:  2012-11-15

9.  The relationships among bone health, insulin-like growth factor-1 and sex hormones in adolescent female athletes.

Authors:  Rita Gruodyte; Jaak Jürimäe; Meeli Saar; Toivo Jürimäe
Journal:  J Bone Miner Metab       Date:  2009-10-15       Impact factor: 2.626

10.  Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats.

Authors:  E K Stuermer; S Sehmisch; M Tezval; H Tezval; T Rack; J Boekhoff; W Wuttke; T R W Herrmann; D Seidlova-Wuttke; K M Stuermer
Journal:  World J Urol       Date:  2009-02-17       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.